(Q33755492)

29 July 2017

1 reference

title

Fusidic acid pharmacology, pharmacokinetics and pharmacodynamics (English)

1 reference

29 July 2017

1 reference

1 reference

1 reference

Turnidge J

1

1 reference

29 July 2017

1 August 1999

1 reference

International Journal of Antimicrobial Agents

29 July 2017

1 reference

29 July 2017

12 Suppl 2

1 reference

29 July 2017

S23-34

1 reference

Aggregation behavior of sodium fusidate in aqueous solution

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900071-5

7 January 2021

Fucidin: a new orally active antibiotic

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900071-5

7 January 2021

Fusidane antibiotics produced by dermatophytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900071-5

7 January 2021

Determination of sodium fusidate and fusidic acid in dosage forms by high-performance liquid chromatography and a microbiological method

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900071-5

7 January 2021

Use of electrophoresis in the identification and quantitation of antibiotics administered in combinations

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900071-5

7 January 2021

High-performance liquid chromatographic determination of fusidic acid in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900071-5

7 January 2021

Liquid chromatographic determination of fusidic acid in serum

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900071-5

7 January 2021

Determination of fusidic acid and sodium fusidate in pharmaceutical dosage forms by first-derivative ultraviolet spectrophotometry

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900071-5

7 January 2021

Spectrophotometric determination of fusidic acid and sodium fusidate in dosage forms

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900071-5

7 January 2021

The absorption of antibiotics in adult patients with coeliac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900071-5

7 January 2021

The disposition of sodium fusidate in man

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900071-5

7 January 2021

Pharmacokinetics and tolerance of a new film-coated tablet of sodium fusidate administered as a single oral dose to healthy volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900071-5

7 January 2021

Pharmacokinetics of sodium fusidate after single and repeated infusions and oral administration of a new formulation

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900071-5

7 January 2021

Antibiotic activity in serum following single and repeated oral administration of sodium fusidate in volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900071-5

7 January 2021

Pharmacokinetics of fusidic acid after a single dose of a new paediatric suspension

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900071-5

7 January 2021

Studies on the absorption and tolerance of a new fucidin suspension

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900071-5

7 January 2021

Pharmacokinetics of intravenous fusidic acid in patients with cholestasis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900071-5

7 January 2021

The pharmacokinetics and protein-binding of fusidic acid in patients with severe renal failure requiring either haemodialysis or continuous ambulatory peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900071-5

7 January 2021

Levels of fusidic acid in skin blister fluid and serum after repeated administration of two dosages (250 and 500 mg)

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900071-5

7 January 2021

The pharmacokinetics of fusidic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900071-5

7 January 2021

Concentrations of fusidic acid, cloxacillin, and cefamandole in sera and atrial appendages of patients undergoing cardiac surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900071-5

7 January 2021

Drug-cholestyramine interactions. II. Influence of cholestyramine on GI absorption of sodium fusidate

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900071-5

7 January 2021

Percutaneous absorption of sodium fusidate and fusidic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900071-5

7 January 2021

Corneal and intraocular penetration of topical and subconjunctival fusidic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900071-5

7 January 2021

Intraocular penetration of fusidic acid with topical Fucithalmic

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900071-5

7 January 2021

Fusidic acid in tear fluid: pharmacokinetic study with fusidic acid viscous eye drops

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900071-5

7 January 2021

A method for studying antibiotic concentrations in inflammatory exudate

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900071-5

7 January 2021

Sputum penetration of fusidic acid in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900071-5

7 January 2021

In vivo penetration of antibiotics into sputum in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900071-5

7 January 2021

Penetration of fusidic acid into human brain tissue and cerebrospinal fluid.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900071-5

7 January 2021

Intraocular penetration of the antibiotic fucidin

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900071-5

7 January 2021

Estimation of sodium fusidate levels in human serum, aqueous humour, and vitreous body

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900071-5

7 January 2021

Interaction of albumin and fusidic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900071-5

7 January 2021

Concentrations of some antibiotics in synovial fluid after oral administration, with special reference to antistaphylococcal activity

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900071-5

7 January 2021

Penetration of Sodium Fusidate (Fucidin) in the Synovial Cavity

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900071-5

7 January 2021

Fusidic acid binding to serum albumin and interaction with binding of bilirubin.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900071-5

7 January 2021

Kinetics and Mechanisms of Drug Action on Microorganisms XX: Integrated Receptor Site Model Rationalizing Observed Microbial Rate Dependencies on Drug Concentration and Microbial Kinetics Affected by Sodium Fusidate

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900071-5

7 January 2021

The postantibiotic effect of fusidic acid against gram-positive bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900071-5

7 January 2021

The post-antibiotic effect of teicoplanin: monotherapy and combination studies

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900071-5

7 January 2021

Efficacy of penicillin G, flucloxacillin, cefazolin, fusidic acid, vancomycin, rifampicin and fosfomycin in muscular infections in mice due to Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900071-5

7 January 2021

10.1016/S0924-8579(98)00071-5

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10528784